DFJ Growth

Activity in this selection2048-ventures-51a15465

By stage

Series C+3

Biotech1

Hardware1

Space tech1

United States3

3 in this selection

Sep 24

An AI and synthetic-biology platform that designs and engineers antibody therapeutics.

$75MSeries C

Lead

Sep 17

Builds highly maneuverable orbital transfer vehicles and kick stages for in-space mobility and satellite logistics

$308MSeries D extension

Role not disclosed

Sep 10

Builds purpose-built hardware and software to make AI inference cheaper and energy-efficient

$875MSeries C

Participant